131 related articles for article (PubMed ID: 30446494)
1. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.
Qu X; Li H; Braziel RM; Passerini V; Rimsza LM; Hsi ED; Leonard JP; Smith SM; Kridel R; Press O; Weigert O; LeBlanc M; Friedberg JW; Fang M
Blood; 2019 Jan; 133(1):81-93. PubMed ID: 30446494
[TBL] [Abstract][Full Text] [Related]
2. Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome.
Yeung CCS; McElhone S; Chen XY; Ng D; Storer BE; Deeg HJ; Fang M
Mod Pathol; 2018 Apr; 31(4):569-580. PubMed ID: 29243741
[TBL] [Abstract][Full Text] [Related]
3. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
Mondello P; Fama A; Larson MC; Feldman AL; Villasboas JC; Yang ZZ; Galkin I; Svelolkin V; Postovalova E; Bagaev A; Ovcharov P; Varlamova A; Huet S; Tesson B; McGrath KR; Slager S; Link BK; Syrbu S; Novak AJ; Habermann TM; Witzig TE; Nowakowski GS; Salles G; Cerhan JR; Ansell SM
Blood Cancer J; 2021 Jul; 11(7):130. PubMed ID: 34267181
[TBL] [Abstract][Full Text] [Related]
4. Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Burack WR; Li H; Adlowitz D; Spence JM; Rimsza LM; Shadman M; Spier CM; Kaminski MS; Leonard JP; Leblanc ML; Smith SM; Friedberg JW
Blood Adv; 2023 Sep; 7(17):5082-5090. PubMed ID: 37379264
[TBL] [Abstract][Full Text] [Related]
5. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract][Full Text] [Related]
6. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
[TBL] [Abstract][Full Text] [Related]
8. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.
Bátai B; Kiss L; Varga L; Nagy Á; Househam J; Baker AM; László T; Udvari A; Horváth R; Nagy T; Csomor J; Szakonyi J; Schneider T; Graham TA; Alpár D; Fitzgibbon J; Szepesi Á; Bödör C
Mod Pathol; 2024 Mar; 37(5):100465. PubMed ID: 38460675
[TBL] [Abstract][Full Text] [Related]
9. Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts.
Sarkozy C; Maurer MJ; Link BK; Ghesquieres H; Nicolas E; Thompson CA; Traverse-Glehen A; Feldman AL; Allmer C; Slager SL; Ansell SM; Habermann TM; Bachy E; Cerhan JR; Salles G
J Clin Oncol; 2019 Jan; 37(2):144-152. PubMed ID: 30481079
[TBL] [Abstract][Full Text] [Related]
10. Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C
Br J Haematol; 2019 Jun; 185(5):951-954. PubMed ID: 30460680
[No Abstract] [Full Text] [Related]
11. Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.
Nijland M; Seitz A; Terpstra M; van Imhoff GW; Kluin PM; van Meerten T; Atayar Ç; van Kempen LC; Diepstra A; Kok K; van den Berg A
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30463380
[TBL] [Abstract][Full Text] [Related]
12. Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma.
Agarwal R; Chan YC; Tam CS; Hunter T; Vassiliadis D; Teh CE; Thijssen R; Yeh P; Wong SQ; Ftouni S; Lam EYN; Anderson MA; Pott C; Gilan O; Bell CC; Knezevic K; Blombery P; Rayeroux K; Zordan A; Li J; Huang DCS; Wall M; Seymour JF; Gray DHD; Roberts AW; Dawson MA; Dawson SJ
Nat Med; 2019 Jan; 25(1):119-129. PubMed ID: 30455436
[TBL] [Abstract][Full Text] [Related]
13. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in follicular lymphoma in Japan and characteristics of the duodenal type.
Yoshino T; Takata K; Tanaka T; Sato Y; Tari A; Okada H
Pathol Int; 2018 Dec; 68(12):665-676. PubMed ID: 30456840
[TBL] [Abstract][Full Text] [Related]
15. Where to start? Upfront therapy for follicular lymphoma in 2018.
Leonard JP; Nastoupil LJ; Flowers CR
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):185-188. PubMed ID: 30504308
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry.
Hohloch K; Windemuth-Kieselbach C; Kolz J; Zinzani PL; Cacchione R; Jurczak W; Bischof Delaloye A; Trümper L; Scholz CW
Br J Haematol; 2019 Mar; 184(6):949-956. PubMed ID: 30515751
[TBL] [Abstract][Full Text] [Related]
17. A small change makes a big difference in Hodgkin lymphoma.
Hutchings M
Blood; 2018 Nov; 132(21):2214-2215. PubMed ID: 30467187
[No Abstract] [Full Text] [Related]
18. Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.
Rivas-Delgado A; Magnano L; Moreno-Velázquez M; García O; Nadeu F; Mozas P; Dlouhy I; Baumann T; Rovira J; González-Farre B; Martínez A; Balague O; Delgado J; Villamor N; Giné E; Campo E; Sancho-Cia JM; López-Guillermo A
Br J Haematol; 2019 Mar; 184(5):753-759. PubMed ID: 30515755
[TBL] [Abstract][Full Text] [Related]
19. Novel immunotherapy approaches to follicular lymphoma.
Flowers CR; Leonard JP; Nastoupil LJ
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):194-199. PubMed ID: 30504310
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation.
Blagitko-Dorfs N; Schlosser P; Greve G; Pfeifer D; Meier R; Baude A; Brocks D; Plass C; Lübbert M
Leukemia; 2019 Apr; 33(4):945-956. PubMed ID: 30470836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]